- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Alpha-1-antichymotrypsin (AACT), encoded by the SERPINA3 gene, is a circulating inhibitor of chymotrypsin-like proteases involved in host defense. Alpha 1-Antichymotrypsin, also called AACT, inhibits the activity of certain proteases, such as cathepsin G that is found in neutrophils, and chymases found in mast cells, by cleaving them into a different shape or conformation. This activity protects some tissues, such as the lower respiratory tract, from damage caused by proteolytic enzymes. This protein is produced in the liver, and is an acute phase protein that is induced during inflammation.
This SERPINA3 antibody is part of a broader set of Alpha-1-antichymotrypsin antibody reagents; for a validation-focused AACT antibody reference including liver expression and protein microarray specificity data, see AACT antibody clone SERPINA3/4184.
The stated application concentrations are suggested starting amounts. Titration of the Alpha-1-Antichymotrypsin antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A human partial recombinant protein was used as the immunogen for this Alpha-1-Antichymotrypsin antibody.
Store the Alpha-1-Antichymotrypsin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.